In a more polite debate than Americans have seen in years, vice presidential candidates JD Vance and Tim Walz argued over abortion, gun violence, mental health and Obamacare.
Abortion, ACA and drug prices: Harris, Trump spar over healthcare in debate
As Vice President Kamala Harris and former President Donald Trump battle over abortion, some 10 states will be voting on reproductive rights measures in November.
Experts suggested the new fair maximum prices achieved from Medicare drug price negotiations might have a more muted effect on the pharma industry than originally anticipated.
Why the Senate passed bills restricting kids’ access to social media
After years of talking about social media’s effects on mental health, lawmakers advanced two bills that would enact restrictions on kids using social media.
Unpacking the PREVAIL Act: What pharma marketers need to know
The Supreme Court unanimously ruled in FDA v. Alliance for Hippocratic Medicine that the plaintiffs lacked a legal right to challenge the health agency’s actions regarding the approval of abortion pill mifepristone.
New dark money group ads emerge in Chinese biotech legislation fight
Ads from a group dubbed “Defend Our DNA” have emerged as lawmakers in debate legislation that would restrict federal business with certain Chinese biotechs.